Charles Q. Morris
2015
In 2015, Charles Q. Morris earned a total compensation of $1.4M as Executive Vice President and Chief Development Officer at ImmunoGen, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $7,083 |
|---|---|
| Non-Equity Incentive Plan | $208,231 |
| Option Awards | $687,438 |
| Salary | $449,696 |
| Other | $92,982 |
| Total | $1,445,430 |
Morris received $687.4K in option awards, accounting for 48% of the total pay in 2015.
Morris also received $7.1K in bonus, $208.2K in non-equity incentive plan, $449.7K in salary and $93K in other compensation.
Rankings
In 2015, Charles Q. Morris' compensation ranked 6,178th out of 13,638 executives tracked by ExecPay. In other words, Morris earned more than 54.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,178 out of 13,638 | 55th |
Division Manufacturing | 2,311 out of 5,190 | 56th |
Major group Chemicals And Allied Products | 832 out of 1,854 | 55th |
Industry group Drugs | 665 out of 1,528 | 57th |
Industry Pharmaceutical Preparations | 519 out of 1,182 | 56th |
Source: SEC filing on September 29, 2015.
Morris' colleagues
We found four more compensation records of executives who worked with Charles Q. Morris at ImmunoGen in 2015.